Renaissance Technologies - CONNECT BIOPHARMA HLDGS LTD ownership

CONNECT BIOPHARMA HLDGS LTD's ticker is CNTB and the CUSIP is 207523101. A total of 26 filers reported holding CONNECT BIOPHARMA HLDGS LTD in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of CONNECT BIOPHARMA HLDGS LTD
ValueSharesWeighting
Q3 2023$79
-26.9%
97,000
+1.6%
0.00%
Q2 2023$108
+21.3%
95,500
+7.2%
0.00%
Q1 2023$89
+21.9%
89,100
+6.2%
0.00%
Q4 2022$73
-99.9%
83,900
+0.7%
0.00%
Q3 2022$107,000
+84.5%
83,300
+24.5%
0.00%
Q2 2022$58,000
-18.3%
66,900
+184.7%
0.00%
Q1 2022$71,000
+26.8%
23,500
+117.6%
0.00%
Q4 2021$56,00010,8000.00%
Other shareholders
CONNECT BIOPHARMA HLDGS LTD shareholders Q3 2022
NameSharesValueWeighting ↓
Sio Capital Management, LLC 597,678$771,0000.24%
Kynam Capital Management, LP 739,649$954,0000.20%
RA Capital Management 6,991,003$9,018,0000.19%
Octagon Capital Advisors LP 450,000$581,0000.10%
Ikarian Capital, LLC 219,501$283,0000.06%
UBS OCONNOR LLC 613,931$792,000,0000.02%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,277,519$1,648,0000.00%
ROCKY MOUNTAIN ADVISERS, LLC 1,200$2,0000.00%
CSS LLC/IL 38,721$50,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 26,867$35,0000.00%
View complete list of CONNECT BIOPHARMA HLDGS LTD shareholders